• Saturday, Jan 16, 2021
  • Last Update : 01:44 am

No room for complacency with Covid-19 cases surging

  • Published at 02:17 pm November 17th, 2020
USA Covid-19
File photo: Residents wait in line for Covid-19 tests at a test site at St Benedict the African Catholic Church in the Englewood neighborhood, in Chicago, Illinois on November 12, 2020 AFP

WHO Chief said the UN agency is 'extremely concerned' by the surge in cases in some countries which is pushing health workers and health systems to breaking point, reports the UN news

Voicing deep concern over the surge of Covid-19 cases, WHO Chief Tedros Adhanom Ghebreyesus has warned about the risk of complacency with the encouraging news about vaccines.

He said the UN agency is “extremely concerned” by the surge in cases in some countries which is pushing health workers and health systems to breaking point, reports the UN news.

Despite encouraging news about Covid-19 vaccines, “this is not the time for complacency,” he said on Monday during his latest press briefing in Geneva.

‘Playing with fire’

WHO and its partners are working with national authorities, to ensure health workers who fall ill will receive proper coverage and that health systems will be ready when safe and effective vaccines are rolled out.

Tedros again highlighted the actions that have helped to prevent Covid-19 spread, such as contact tracing and cluster investigations, noting that countries that have invested in these areas are facing much less disruption. 

“Those countries that are letting the virus run unchecked are playing with fire,” he stated

The WHO chief stressed the need for greater action to support health workers but also to keep schools open, protect the vulnerable and safeguard the economy. 

Encouraging but cautious

Although welcoming the latest news on Covid-19 vaccines, WHO is awaiting further data on these potential treatments.

Biotech company Moderna announced on Monday that its experimental vaccine has shown a nearly 95% efficacy rate, according to interim results.

This follows a recent similar announcement by pharmaceutical companies Pfizer and BioNTech.

Responding to a journalist’s question, WHO Chief Scientist Dr Soumya Swaminathan called the development “quite encouraging”, while also expressing caution.

“Of course, we need to wait and see what the final efficacy and the safety profile of this vaccine will be when the whole data is analysed after they reach their primary endpoint, and also have enough follow-up of at least two months of half the trial participants for the side effects.  And that will then be submitted to the regulatory agencies,” she said.

Ensuring equitable access

The Moderna vaccine is among nine candidates in the Covax Facility: a global initiative for equitable vaccine access led by Gavi, the Vaccine Alliance; the Coalition for Epidemic Preparedness Innovations (CEPI), and WHO.

More than 170 countries have joined the Facility, including some 92 low- and middle-income nations.

Discussions with several vaccine manufacturers from across the world is ongoing, said Dr Swaminathan, who explained other considerations for procurement besides efficacy and safety.

“There is an independent prioritization group that is being set up that will look at the dossiers, that will look at the data, that manufacturers are submitting,” she told the briefing. 

“Then there are the cost considerations as well. There is the affordability, and then there are practical considerations like the need for cold storage, the number of doses of vaccine that will be required, the number of doses that may be available early in 2021.”

Limited supplies

Swaminathan expressed hope that results from other vaccine trials currently underway will be released in the coming weeks.

She underscored the need for the Covax Facility to have the widest possible selection of vaccine candidates as some will be more applicable in certain situations, or among sub-groups such as the elderly, for example.

“I think we’re looking at least the first half of next year, as being a period of very, very limited doses,” she said.  

“Supplies are going to be limited. There are bilateral deals that many of the companies have done, so many of the doses have already been booked by some countries.”

She stressed the overall goal of ensuring that health workers and others at high risk of Covid-19 are protected wherever they are located, underscoring the need for global solidarity.

52
Facebook 51
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail